相关实验视频

Updated: Jul 10, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.4K

基于数字患者报告的结局数据对多发性骨髓瘤和其他M蛋白疾病患者进行后续化疗的决策 - 混合方法研究

Tine Rosenberg1, Jannie Kirkegaard2, Michael Gundesen Tveden1

  • 1Department of Hematology, Odense University Hospital, Kloevervaenget 10, 12th Floor, 5000, Odense C, Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, DK-5000, Odense C, Denmark.

European journal of oncology nursing : the official journal of European Oncology Nursing Society
|November 20, 2023
PubMed
概括

患者报告结果 (PRO) 数据有效地确定了对博特佐米布治疗的准备程度,减少了对面咨询的需要. 这种安全可行的方法赋予了患者权力,并简化了对多发性骨髓瘤和相关疾病的护理.

关键词:
不良影响不良影响抗瘤治疗是一种治疗方法.应用程序 应用程序 应用程序化疗 化疗是一种化学疗法.赋权赋权就是赋权.在M组分分泌不良的情况下,M组分分泌不良.移动应用程序 移动应用程序多发性骨髓瘤是一种多发性骨髓瘤.患者报告的结果衡量患者报告的结果.副作用 副作用 副作用 副作用

更多相关视频

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

294

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K